|
DT120 Clinical Trials
1 actively recruiting trial across 1 location
Also known as: MM120, lysergide tartrate
Pipeline
Phase 3: 1
Top Sponsors
- Definium Therapeutics US, Inc.1
Indications
- Major Depressive Disorder1
- Depression1
Gilbert, Arizona1 trial
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Lighthouse Psychiatry
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.